New rabies vaccine passes first safety check in small human trial
NCT ID NCT07338786
First seen Jan 15, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This early-stage trial tests whether a new freeze-dried rabies vaccine is safe for people. Eighty healthy volunteers aged 10 to 60 received the vaccine and were monitored for side effects for 30 days. The goal is to prevent rabies, not to treat it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIESPREVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangsu CDC
Xuzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.